CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 18 enrolled
Drug / intervention
quinine sulfate +1 moredrug
Likely dose
quinine sulfate 324 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00806078
NCT00806078Phase 1Completed
CompareCT.gov

A Comparison of the Bioavailability of Quinine Sulfate Capsules Following a 648 mg Dose When Mixed in Chocolate Pudding Relative to That With Intact Capsules in Healthy Adults Under Fasting Conditions

Mutual Pharmaceutical Company, Inc.·interventional·Posted Dec 10, 2008·Updated Aug 31, 2012

In Brief

A Phase 1 clinical trial evaluating quinine sulfate for Healthy. Completed, enrolled 18 participants across 1 site.

Detailed Summary

This is an open label randomized single dose two-way crossover study to compare the bioavailability of a single oral dose of quinine sulfate 648 mg(2 x 324 mg) when mixed with 120 ml of chocolate pudding relative to the same dose given as two intact capsules.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
Collaborators--

Timeline

Phase 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2008
Enrollment StartJul 1, 2007
Primary CompletionAug 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.6 years ago

Interventions

quinine sulfatedrug

2 x 324 mg capsules (648 mg)

quinine sulfatedrug

2 x 324 mg capsules (648 mg)